This document reviews 1) the measurement properties of commonly used exercise tests in
patients with chronic respiratory diseases and 2) published studies on their utilty and/or …

The clinical expression of idiopathic pulmonary fibrosis (IPF) is directly related to multiple
alterations in lung function. These alterations derive from a complex disease process …

Background: Evidence-based guidelines are needed for effective delivery of home oxygen
therapy to appropriate patients with chronic obstructive pulmonary disease (COPD) and …

Progressive fibrotic interstitial lung diseases (ILDs) are characterised by major reductions in
quality of life and survival and have similarities to certain malignancies. However, palliative …

This review aims to establish the impact of oxygen therapy on dyspnoea, health-related
quality of life (HRQoL), exercise capacity and mortality in interstitial lung disease (ILD). We …

Background and objective Supplemental oxygen is commonly prescribed in patients with
idiopathic pulmonary fibrosis (IPF), although its benefits have not been proven. The aims of …

Idiopathic pulmonary fibrosis (IPF) is a fibrotic lung disease of unknown cause characterized
by relentlessly progressive restrictive-ventilatory limitation, hypoxia, dyspnea, and cough …

While high-level evidence is lacking, numerous retrospective studies have depicted the
value of supplemental oxygen in idiopathic pulmonary fibrosis (IPF) and other interstitial …

Background A large subgroup of people with interstitial lung disease (ILD) are normoxic at
rest, but rapidly desaturate on exertion. This can limit exercise capacity and worsen …

Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease (ILD) of unknown
aetiology with a median survival of only 2–5 years. It is characterized by progressive …